Tag:
Hepcludex
Internal Medicine
The FDA has approved Hepcludex, the first drug for the treatment of chronic hepatitis D
On May 22, 2026, the U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) as the first medication for the treatment of chronic hepatitis...